ReleaseWire Connect

Kuros Biosurgery AG (Kuros) is a biomedical company engaged in the development of biomaterial products. It develops a broad range of bioactive wound care products, bone graft substitutes and bioactive spinal products. The company's hard and soft tissue repair products are used in biosurgery and orthobiologics markets. Kuros developed a broad pipeline of products that are currently at various stages of clinical and pre-clinical development within the core areas of trauma, wound and spine. Kuros has two biomaterial technology platforms, one based on fibrin sealants and the other based on its own proprietary synthetic technology. Kuros is headquartered in Zurich, Switzerland

In January 2011, Boots Retail Ireland Ltd announced that it would begin supplying emergency contraception without prescription. This was due to a provision found in the amendment to legislation in 2005 relating to emergency contraception, which states that emergency contraception can be offered by "qualified medical professionals" under protocols set out by a medical professional such as a doctor. Boots stores began offering the morning after pill, Levonelle, one of two products available in...

2011 was an atypical year, marked by the poor performance of the largest direct selling companies present in the country, such as Natura Cosmeticos and Avon Cosmeticos, which reported that the disappointing results in the year were related to internal structural problems. Otherwise, Botica Comercial Farmaceutica (O Boticario) invested in new launches and in advertising campaigns on television, and sponsored fashion events such as Sao Paulo Fashion Week, amongst other marketing strategies,...

BMI's Australia Defence and Security report for Q312 examines the country's strategic position in the Pacific region and the wider world. It provides an overview of the contemporary geopolitical challenges facing the country, and the challenges it may face in the future.

The 2011-20 forecast period will see the loss of exclusivity for the leading non-insulin antidiabetic Actos franchise, while new launches include the first once-weekly GLP-1 agonists and the oral SGLT-2 inhibitor class, to compete in an increasingly crowded treatment algorithm in type 2 diabetes. This report was updated in May 2012 to reflect recent developments in the market.

Greece's worsening economic conditions over the past five years will continue to have an adverse effect on its mining industry. Greece is one of the leading producers of bentonite and perlite in the world. Other key minerals in the country include bauxite, nickel and gold. Greek mining production volumes of (coal, nickel, bauxite, perlite and bentonite) is expected to decline by 3.2% in 2012. Mining production volume shrank by -6.62% during the review period (2007-2011), although it is projected to grow at a CAGR of 2.52% over the forecast period (2012-2016). The current decline in production volumes is mainly due to the recession that has affected the country during the review period. The production of coal and bauxite declined during 2010-2011, and this decline is expected to continue in 2012. However, the production of nickel, perlite and bentonite registered a positive growth during the same period, and is projected to continue growing over the forecast period. Coal production volume fell during the review period, although it is projected to grow at a CAGR of 1.14% over the forecast period. Coal is primarily used for power generation in Greece. During the review period, the demand for power in Greece declined as the country's industrial activity slowed due to poor economic conditions.

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in France. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the natural gas assets (gas fields, pipelines, LNG terminals and underground gas storage facilities) in France. The report compares the investment environment in France with other countries in the region. The profiles of the major companies operating in the natural gas sector in France together with the latest news and deals are also included in the report.

While the general trend in mature markets is for declining average mileage in lieu of higher vehicle ownership ratios per household, the ongoing economic stagnation is causing motorists to seek financial savings by substituting vehicle use, thus decelerating their vehicles' wear rates and as a result reducing consumption of service parts on an annual basis.

This report offers detailed analysis of the global Military Simulations and Virtual Training market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Military Simulations and Virtual Training market.

GlobalData, the industry analysis specialist, has released its new report, "Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Acute Pain Therapeutics market. The report identifies the key trends shaping and driving the global Acute Pain Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Acute Pain Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.